The Generics Industry in India is analyzed through an industry overview which spans the data from 2012 till 2021. An analysis of the industry's value and volume data is included along with an industry segmentation by geography. Industry forecast of the industry is also included.
We also include a Porter's Five Forces analysis of the Indian Generics Industry. Generics pricing and reimbursement situation in India and trends and challenges facing the industry are analyzed.
Analysis of the major industry players in the Indian generics market are analyzed through an analysis of their business segments, a financial analysis and a SWOT analysis. Players analyzed include Cipla Limited, Lupin, Mylan, Sanofi SA, Teva Pharmaceutical Industries, Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd. and Sandoz International.
Key Topics Covered:
A. Executive Summary
B. Analyzing the Global Generics Industry
C. Generics Industry in Asia Pacific
D. Generics Industry in India
E. Generics Industry in India: Porter's Five Forces Strategy Analysis
F. Pricing & Reimbursement in India
G. Major Industry Players
- Aurobindo Pharma Limited
- Cipla Limited
- Lupin Limited
- Mylan N.V.
- Sandoz International GmbH
- Sanofi SA
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Limited
For more information about this report visit http://www.researchandmarkets.com/research/mlntqp/analyzing